Establishment and characterization of a KIT-positive and stem cell factor-producing cell line, KTHOS, derived from human osteosarcoma

Pathology International

Volumn 55, Issue 2, 2005, Pages 41-47

  Hitora, Toshiaki ^a   Yamamoto, Tetsuji ^a   Akisue, Toshihiro ^a   Marui, Takashi ^a   Nakatani, Tetsuya ^a   Kawamoto, Teruya ^a   Nagira, Keiko ^a   Yoshiya, Shinichi ^a   Kurosaka, Masahiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell line; KIT; Osteosarcoma; Stem cell factor

Indexed keywords

COMPLEMENTARY DNA; OSTEOCALCIN; OSTEONECTIN; RNA; STEM CELL FACTOR;

ANIMAL MODEL; ARTICLE; BONE CANCER; CANCER CELL CULTURE; CELL GROWTH; CELL LINE; CELL LINE KTHOS; CONTROLLED STUDY; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; XENOTRANSPLANTATION;

ADOLESCENT; ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; OSTEOBLASTS; OSTEOCALCIN; OSTEOPONTIN; OSTEOSARCOMA; PROTO-ONCOGENE PROTEINS C-KIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SIALOGLYCOPROTEINS; STEM CELL FACTOR;

EID: 14844322930     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2005.01787.x     Document Type: Article

References (23)

1. Papagelopoulos PJ, Galanis EC, Vlastou C et al. Current concepts in the evaluation and treatment of osteosarcoma. Orthopedics 2000; 23: 858-67.
2. Landuzzi L, De Giovanni C, Nicoletti G et al. The metastatic ability of Ewing's sarcoma cell is modulated by stem cell factor and its receptor c-kit. Am J Pathol 2000; 157: 2123-31.
3. Welker P, Grabbe J, Gibbs B, Zuberbier T, Henz BM. Nerve growth factor-β induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology 2000; 99: 418-26.
4. Adler H, Frech B, Thöny M, Pfister H, Peterhans E, Jungi TW. Inducible nitric oxide synthase in cattle. Differential cytokine regulation of nitric oxide synthase in bovine and murine macrophages. J Immunol 1995; 154: 4710-18.
5. Yoshikawa H, Ohishi M, Kohriki S, Yoshiura M, Ohsaki Y. Establishment and characterization of an osteoblastic clonal cell line from Human Mandibular Osteosarcoma (HMOS-1). Oral Oncol 1997; 33: 163-8.
6. Bilbe G, Roberts E, Birch M, Evans DB. PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines. Bone 1996; 19: 437-45.
7. Tsuda T, Masuhara K, Yoshikawa H, Shimizu N, Takaoka K. Establishment of an osteoinductive murine osteosarcoma clonal cell line showing osteoblastic phenotypic traits. Bone 1989; 10: 195-200.
8. Minamitani K. Establishment of an osteoblastic osteosarcoma cell line and effects of cell culture conditions on secretion of matrix metalloproteinases from the cultured osteosarcoma cells. Kurume Med J 2000; 47: 115-24.
9. Rochet N, Dubousset J, Mazeau C et al. Establishment, characterization and partial cytokine expression profile of a new human osteosarcoma cell line (CAL72). Int J Cancer 1999; 82: 282-5.
10. Oda Y, Wehrmann B, Radig K et al. Expression of growth factors and their receptors in human osteosarcomas. Immunohistochemical detection of epidermal growth factor, platelet-derived growth factor and their receptors: its correlation with proliferation activities and p53 expression. Gen Diagn Pathol 1995; 141: 97-103.
11. Smithey BE, Pappo AS, Hill DA. c-Kit expression in pediatric solid tumors. Am J Surg Pathol 2002; 26: 486-92.
12. Taichman RS, Emerson SG. Human osteosarcoma cell lines MG-63 and SaOS-2 produce G-CSF and GM-CSF: identification and partial characterization of cell-associated isoforms. Exp Hematol 1996; 24: 509-17.
13. Nakatani T, Marui T, Yamamoto T et al. Expression of stem cell factor and c-kit in human malignant fibrous histiocytoma cell line (TNMY1). Anticancer Res 2003; 23: 2329-34.
14. Tamborini E, Papini D, Mezzelani A et al. c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases. Br J Cancer 2001; 85: 405-11.
15. Landuzzi L, Strippoli P, De Giovanni C et al. Production of stem cell factor and expression of c-kit in human rhabdomyosarcoma cells: lack of autocrine growth modulation. Int J Cancer 1998; 78: 441-5.
16. Beck D, Gross N, Beretta Brognara C, Perruisseau G. Expression of stem cell factor and its receptor by human neuroblastoma cells and tumors. Blood 1995; 86: 3132-8.
17. Krystal GW, Hines SJ, Organ CP. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. Cancer Res 1996; 56: 370-76.
18. Hassan S, Kinoshita Y, Kawanami C et al. Expression of protooncogene c-kit and its ligand stem cell factor (SCF) in gastric carcinoma cell lines. Dig Dis Sci 1998; 43: 8-14.
19. Ricotti E, Fagioli F, Garelli E et al. c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells. Blood 1998; 91: 2397-405.
20. Turner AM, Zsebo KM, Martin F et al. Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 1992; 80: 374-81.
21. Hotfilder M, Lanvers C, Jürgens H, Boos J, Vormoor J. c-kit-expressing ewing tumour cells are insensitive to imatinib mestylate (STI571). Cancer Chemother Pharmacol 2002; 50: 167-9.
22. Druker BJ, Lydon NB. Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J Clin Invest 2000; 105: 3-7.
23. Buchdunger E, Cioffi CL, Law N et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 2000; 295: 139-45.